Validation of a clinical calculator predicting freedom from colon cancer recurrence after surgery on the basis of molecular and clinical variables Journal Article


Authors: Khan, A.; Thompson, H. M.; Hsu, M.; Widmar, M.; Wei, I. H.; Pappou, E.; Smith, J. J.; Nash, G. M.; Paty, P. B.; Garcia-Aguilar, J.; Shia, J.; Gönen, M.; Weiser, M.
Article Title: Validation of a clinical calculator predicting freedom from colon cancer recurrence after surgery on the basis of molecular and clinical variables
Abstract: BACKGROUND: The Memorial Sloan Kettering clinical calculator for estimating the likelihood of freedom from colon cancer recurrence on the basis of clinical and molecular variables was developed at a time when testing for microsatellite instability was performed selectively, based on patient age, family history, and histologic features. Microsatellite stability was assumed if no testing was done. OBJECTIVE: This study aimed to validate the calculator in a cohort of patients who had all been tested for microsatellite instability. DESIGN: Retrospective cohort analysis. SETTINGS: Comprehensive cancer center. PATIENTS: This study included consecutive patients who underwent curative resection for stage I, II, or III colon cancer between 2017 and 2019. INTERVENTION: Universal testing of mircrosatellite phenotype in all cases. MAIN OUTCOME MEASURES: The calculator’s predictive accuracy was assessed using the concordance index and a calibration plot of predicted versus actual freedom from recurrence at 3 years after surgery. For a secondary sensitivity analysis, the presence of a tumor deposit(s) (disease category N1c) was considered equivalent to one positive lymph node (category N1a). RESULTS: With a median follow-up of 32 months among survivors, the concordance index for the 745 patients in the cohort was 0.748 (95% CI, 0.693–0.801), and a plot of predicted versus observed recurrences approached the 45° diagonal, indicating good discrimination and calibration. In the secondary sensitivity analysis for tumor deposits, the concordance index was 0.755 (95% CI, 0.700–0.806). LIMITATIONS: This study was limited by its retrospective, single-institution design. CONCLUSIONS: These results, based on inclusion of actual rather than imputed microsatellite stability status and presence of tumor deposits, confirm the predictive accuracy and reliability of the calculator. See Video Abstract. © The ASCRS 2023.
Keywords: adult; cancer survival; controlled study; aged; middle aged; cancer surgery; retrospective studies; major clinical study; genetics; clinical feature; cancer recurrence; postoperative period; cancer staging; follow up; lymph node metastasis; neoplasm staging; prospective study; sensitivity analysis; reproducibility; reproducibility of results; phenotype; clinical assessment; calibration; colonic neoplasms; cohort analysis; pathology; validation study; retrospective study; molecular mechanics; nomograms; colon cancer; colon tumor; microsatellite instability; kaplan meier method; nomogram; predictive value; clinical outcome; extranodal extension; humans; prognosis; human; male; female; article
Journal Title: Diseases of the Colon and Rectum
Volume: 67
Issue: 2
ISSN: 0012-3706
Publisher: Lippincott Williams & Wilkins  
Date Published: 2024-02-01
Start Page: 240
End Page: 245
Language: English
DOI: 10.1097/dcr.0000000000002896
PUBMED: 37815326
PROVIDER: scopus
PMCID: PMC10843082
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Martin R. Weiser -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Meier Hsu
    169 Hsu
  2. Philip B Paty
    499 Paty
  3. Mithat Gonen
    1029 Gonen
  4. Jinru Shia
    720 Shia
  5. Martin R Weiser
    538 Weiser
  6. Garrett Nash
    263 Nash
  7. Jesse Joshua Smith
    221 Smith
  8. Maria   Widmar
    76 Widmar
  9. Emmanouil Pappou
    91 Pappou
  10. Iris Hsin - chu Wei
    66 Wei
  11. Asama Khan
    12 Khan